186 related articles for article (PubMed ID: 17576778)
41. Heat shock protein 27 mediated signaling in viral infection.
Rajaiya J; Yousuf MA; Singh G; Stanish H; Chodosh J
Biochemistry; 2012 Jul; 51(28):5695-702. PubMed ID: 22734719
[TBL] [Abstract][Full Text] [Related]
42. The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress.
Grierson PM; Dodhiawala PB; Cheng Y; Chen TH; Khawar IA; Wei Q; Zhang D; Li L; Herndon J; Monahan JB; Ruzinova MB; Lim KH
Sci Transl Med; 2021 Dec; 13(622):eabb5445. PubMed ID: 34851698
[TBL] [Abstract][Full Text] [Related]
43. MAPK-activated protein kinase 2-deficiency causes hyperacute tumor necrosis factor-induced inflammatory shock.
Vandendriessche B; Goethals A; Simats A; Van Hamme E; Brouckaert P; Cauwels A
BMC Physiol; 2014 Sep; 14():5. PubMed ID: 25185746
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor.
Lopes LB; Flynn C; Komalavilas P; Panitch A; Brophy CM; Seal BL
Biochem Biophys Res Commun; 2009 May; 382(3):535-9. PubMed ID: 19289101
[TBL] [Abstract][Full Text] [Related]
45. Noxa/HSP27 complex delays degradation of ubiquitylated IkBα in airway epithelial cells to reduce pulmonary inflammation.
Zhang C; Jones JT; Chand HS; Wathelet MG; Evans CM; Dickey B; Xiang J; Mebratu YA; Tesfaigzi Y
Mucosal Immunol; 2018 May; 11(3):741-751. PubMed ID: 29363670
[TBL] [Abstract][Full Text] [Related]
46. Rbm10 regulates inflammation development via alternative splicing of Dnmt3b.
Atsumi T; Suzuki H; Jiang JJ; Okuyama Y; Nakagawa I; Ota M; Tanaka Y; Ohki T; Katsunuma K; Nakajima K; Hasegawa Y; Ohara O; Ogura H; Arima Y; Kamimura D; Murakami M
Int Immunol; 2017 Dec; 29(12):581-591. PubMed ID: 29309623
[TBL] [Abstract][Full Text] [Related]
47. MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells.
Schwermann J; Rathinam C; Schubert M; Schumacher S; Noyan F; Koseki H; Kotlyarov A; Klein C; Gaestel M
EMBO J; 2009 May; 28(10):1392-406. PubMed ID: 19369945
[TBL] [Abstract][Full Text] [Related]
48. Phosphorylated Hsp27 prevents LPS-induced excessive inflammation in THP-1 cells via suppressing ROS-mediated upregulation of CBP.
Bi X; Jiang B; Zhou J; Luo L; Yin Z
Cell Biol Int; 2020 Jan; 44(1):253-267. PubMed ID: 31483551
[TBL] [Abstract][Full Text] [Related]
49. IL-33-activated murine mast cells control the dichotomy between RORγt
Andreas N; Weber F; Meininger I; Templin N; Gaestel M; Kamradt T; Drube S
Eur J Immunol; 2019 Dec; 49(12):2159-2171. PubMed ID: 31334837
[TBL] [Abstract][Full Text] [Related]
50. MK2 drives progression of pancreas and colon cancers by suppressing CD8
Jacenik D; Lebish EJ; Beswick EJ
Front Immunol; 2023; 14():1212100. PubMed ID: 37415974
[TBL] [Abstract][Full Text] [Related]
51. Prevention of Melanoma Extravasation as a New Treatment Option Exemplified by p38/MK2 Inhibition.
Petzelbauer P
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172202
[TBL] [Abstract][Full Text] [Related]
52. NF-κB, inflammation, and metabolic disease.
Baker RG; Hayden MS; Ghosh S
Cell Metab; 2011 Jan; 13(1):11-22. PubMed ID: 21195345
[TBL] [Abstract][Full Text] [Related]
53. Ammonia induces Treg/Th1 imbalance with triggered NF-κB pathway leading to chicken respiratory inflammation response.
Shi Q; Wang W; Chen M; Zhang H; Xu S
Sci Total Environ; 2019 Apr; 659():354-362. PubMed ID: 30599354
[TBL] [Abstract][Full Text] [Related]
54. Role of MK2 signaling pathway in the chronic compression of cervical spinal cord.
Song H; Fang X; Wen M; Yu F; Gao K; Sun C; Wang Z
Am J Transl Res; 2015; 7(11):2355-63. PubMed ID: 26807183
[TBL] [Abstract][Full Text] [Related]
55. Muscle fatigue: MK2 signaling and myofibroblast differentiation.
Hagood JS; Olman MA
Am J Respir Cell Mol Biol; 2007 Nov; 37(5):503-6. PubMed ID: 17940320
[No Abstract] [Full Text] [Related]
56. Gene silencing of MK2 in hard-to-transfect human U937 cells.
Tietz SM; Berghoff M
J Biomol Tech; 2012 Jul; 23(2):47-50. PubMed ID: 22951959
[TBL] [Abstract][Full Text] [Related]
57. Vascular control of inflammatory oedema.
Warren JB
Clin Sci (Lond); 1993 Jun; 84(6):581-4. PubMed ID: 8334803
[No Abstract] [Full Text] [Related]
58. Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder.
Blackwell TS; Stecenko AA; Christman JW
Am J Physiol Lung Cell Mol Physiol; 2001 Jul; 281(1):L69-70. PubMed ID: 11404247
[No Abstract] [Full Text] [Related]
59. MK2 is a therapeutic target for high-risk multiple myeloma.
Gu C; Cheng H; Yang H; Bian Y; Wang Y; Zhang Y; Pisano M; Hu G; Yang Y
Haematologica; 2021 Jun; 106(6):1774-1777. PubMed ID: 29567777
[No Abstract] [Full Text] [Related]
60. Cross-species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammation.
Suarez-Lopez L; Shui B; Brubaker DK; Hill M; Bergendorf A; Changelian PS; Laguna A; Starchenko A; Lauffenburger DA; Haigis KM
iScience; 2021 Dec; 24(12):103406. PubMed ID: 34849469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
